510(k) · Cleared
ClearedCleveland Multiport Ventricular Catheter Set
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Parker Hannifin Corp. · HCA Catheter, Ventricular
Cleared on Mar 27, 2017 as substantially equivalent to K123605 (Mri Interventions, Inc., 2013) and 2 other predicates after a 277-day review. Its family tree reaches back 2 generations to 2011.
- Decided
- Mar 27, 2017
- Review
- 277 days
- Class
- Class II
- Product code
- HCA
- Recalls
- None
- Predicates
- 3
Its longest line of descent runs back 2 generations to K102101 (2011). 3 ancestors in all. No later device cites it as a predicate yet.
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −2 | K102101 | Surgivision MR Compatible Ventricular Cannula | Surgivision, Inc. | 2011 | — |
| −1 | K123605 | Smartflow Catheter | Mri Interventions, Inc. | 2013 | — |
| 0 (this device) | K161731 | Cleveland Multiport Ventricular Catheter Set | Parker Hannifin Corp. | 2017 | — |
Other ancestors by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 2015 | 1 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in HCA? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
- Candidate predicates for a device like this, rankedin the report
- Recall history across each candidate’s familyin the report
What was it cleared against? (3)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K123605 | Smartflow CatheterSummary page 4…ode: HCA Device Classification: 21 CFR 882.4100 Regulatory Class: Class II Predicate Device: MRI SmartFlow Flex Ventricular Catheter #K123605. Intended Use / Indications for Use The Cleveland Multiport Ventricular Catheter Set is indicated for gaining access to the vent… | 2013 |
| * | K150660 | Alcyone MEMS Cannula (AMC) SystemSummary page 6…tricular Ventricular Catheter, Cannula System, Ventricular Cannula, Catheter Set K123605 K150660 K102101 Classification 21 CFR 882.4100 21 CFR 882.4100 21 CFR 882.4060… | 2015 |
| * | K102101 | Surgivision MR Compatible Ventricular CannulaSummary page 6…atheter, Cannula System, Ventricular Cannula, Catheter Set K123605 K150660 K102101 Classification 21 CFR 882.4100 21 CFR 882.4100 21 CFR 882.4060 21 CFR 882.4060… | 2011 |
What descends from it?
No later submission names this one as a predicate yet.
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
What does this lineage say?
- The line of descent spans 6 years and passes through 3 companies; a new generation was cleared every 3.6 years on median.
- None of the 3 ancestors has a recall.
How does its category compare?
All HCA devicesHCA Catheter, Ventricular: FDA decisions, review times, recalls and adverse event reports over 20 years. 2017, this device’s year, is highlighted.
FDA decisions per year · HCA
1in 2017
2026 to Oct 25, outlined.
Median 510(k) review, days · HCA
Too few HCA 510(k)s in any year since 2007 to give a median.
Recalls per year · HCA
No recall names HCA since 2007.
Adverse event reports per year · HCA
1in 2021
MAUDE reports naming product code HCA, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 0 | — | 0 | 8 |
| 2008 | 0 | — | 0 | 3 |
| 2009 | 0 | — | 0 | 1 |
| 2010 | 0 | — | 0 | 4 |
| 2011 | 0 | — | 0 | 19 |
| 2012 | 0 | — | 0 | 1 |
| 2013 | 1 | — | 0 | 0 |
| 2014 | 0 | — | 0 | 0 |
| 2015 | 0 | — | 0 | 2 |
| 2016 | 0 | — | 0 | 1 |
| 2017 | 1 | — | 0 | 3 |
| 2018 | 0 | — | 0 | 0 |
| 2019 | 0 | — | 0 | 2 |
| 2020 | 0 | — | 0 | 1 |
| 2021 | 0 | — | 0 | 1 |
| 2022 | 0 | — | 0 | 0 |
| 2023 | 0 | — | 0 | 0 |
| 2024 | 0 | — | 0 | 0 |
| 2025 | 0 | — | 0 | 0 |
| 2026 | 0 | — | 0 | — |
What is it indicated for?
The Cleveland Multiport Ventricular Catheter Set is indicated for gaining access to the ventricles of the brain for the
removal of cerebrospinal fluid (CSF) or for injecting Cytarabine.
Indications for use as stated in the FDA summary.
https://510kreport.com/device/K161731 · printed Nov 6, 2026
Cite this page
510(k) Report. “K161731: Cleveland Multiport Ventricular Catheter Set.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K161731
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026